CERO Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CERO Therapeutics's estimated annual revenue is currently $1.7M per year.
- CERO Therapeutics's estimated revenue per employee is $155,000
Employee Data
- CERO Therapeutics has 11 Employees.
- CERO Therapeutics grew their employee count by -31% last year.
CERO Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Sr. Director | Reveal Email/Phone |
3 | Founder and Chief Technology Officer | Reveal Email/Phone |
4 | Sr. Scientist /Assoc. Director | Reveal Email/Phone |
5 | Principal Scientist | Reveal Email/Phone |
6 | Scientist | Reveal Email/Phone |
7 | Principal Scientist - Viral Vector | Reveal Email/Phone |
8 | SRA | Reveal Email/Phone |
9 | Senior Research Associate | Reveal Email/Phone |
10 | Senior Research Associate | Reveal Email/Phone |
CERO Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is CERO Therapeutics?
At CERo, we are expanding the armamentarium of engineered cell therapies to create a whole new class of innovative medicines for oncology. Armed with an understanding of cellular clearance and molecular immunology, we engineer cells to engage new and complementary cell elimination pathways to enable deeper and more sustained clinical responses to maximize wellness.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CERO Therapeutics News
2022-04-17 - MarketsandMarkets Biopharma Series - Healthcare Trends, Innovations & Disruptions Under One Roof!
Immune Checkpoint Inhibitors and Combination Therapies. ... Senior Vice President, Head, Translational Medicine, CERo Therapeutics
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 11 | -31% | N/A |
#2 | $1.7M | 11 | N/A | N/A |
#3 | $0.9M | 11 | -8% | N/A |
#4 | $0.9M | 12 | -76% | $38M |
#5 | $1.9M | 12 | -8% | N/A |